rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2010-4-30
|
pubmed:abstractText |
Chronic obstructive pulmonary disease (COPD) is characterized by airway inflammation and remodeling. High-mobility group box 1 (HMGB1), a nuclear protein that is released during inflammation and repair, interacts with proinflammatory cytokines and with the receptor for advanced glycation end products (RAGE), which is highly expressed in the lung.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1535-4970
|
pubmed:author |
pubmed-author:AubierMichelM,
pubmed-author:CoyleAnthony JAJ,
pubmed-author:DombretMarie-ChristineMC,
pubmed-author:FerhaniNassimaN,
pubmed-author:GrandsaigneMartineM,
pubmed-author:KolbeckRolandR,
pubmed-author:KozhichAlexanderA,
pubmed-author:LetuveSéverineS,
pubmed-author:MaretMarielleM,
pubmed-author:PretolaniMarinaM,
pubmed-author:SimsGary PGP,
pubmed-author:ThibaudeauOlivierO
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
181
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
917-27
|
pubmed:meshHeading |
pubmed-meshheading:20133931-Airway Remodeling,
pubmed-meshheading:20133931-Bronchi,
pubmed-meshheading:20133931-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:20133931-Cell Line,
pubmed-meshheading:20133931-Female,
pubmed-meshheading:20133931-Fluorescent Antibody Technique,
pubmed-meshheading:20133931-Forced Expiratory Flow Rates,
pubmed-meshheading:20133931-HMGB1 Protein,
pubmed-meshheading:20133931-Humans,
pubmed-meshheading:20133931-Immunohistochemistry,
pubmed-meshheading:20133931-Interleukin-1beta,
pubmed-meshheading:20133931-Lung,
pubmed-meshheading:20133931-Macrophages, Alveolar,
pubmed-meshheading:20133931-Male,
pubmed-meshheading:20133931-Middle Aged,
pubmed-meshheading:20133931-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:20133931-Receptors, Immunologic,
pubmed-meshheading:20133931-Smoking
|
pubmed:year |
2010
|
pubmed:articleTitle |
Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
|
pubmed:affiliation |
Institut National de la Santé et de la Recherche Médicale (INSERM) U700, Physiopathologie et Epidémiologie de l'Insuffisance Respiratoire, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|